Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Forbion, a prominent biotech investor, raises $2.6B for a pair of venture funds

The fundraise is the firm’s largest to date, providing a lift for a European biotech industry that’s fallen further behind its counterparts in the U.S. and China.

We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.

Read the original at biopharmadive.com →

More in Health & Medicine

More from Tuesday 6 October →